留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

严重烧伤感染与细胞因子风暴的研究进展

陈仲毅 胡时强 刘德伍 张红艳 郭光华 毛远桂

陈仲毅, 胡时强, 刘德伍, 等. 严重烧伤感染与细胞因子风暴的研究进展[J]. 中华烧伤与创面修复杂志, 2023, 39(4): 391-395. DOI: 10.3760/cma.j.cn501225-20220412-00134.
引用本文: 陈仲毅, 胡时强, 刘德伍, 等. 严重烧伤感染与细胞因子风暴的研究进展[J]. 中华烧伤与创面修复杂志, 2023, 39(4): 391-395. DOI: 10.3760/cma.j.cn501225-20220412-00134.
Chen ZY,Hu SQ,Liu DW,et al.Research advances on severe burn infection and cytokine storm[J].Chin J Burns Wounds,2023,39(4):391-395.DOI: 10.3760/cma.j.cn501225-20220412-00134.
Citation: Chen ZY,Hu SQ,Liu DW,et al.Research advances on severe burn infection and cytokine storm[J].Chin J Burns Wounds,2023,39(4):391-395.DOI: 10.3760/cma.j.cn501225-20220412-00134.

严重烧伤感染与细胞因子风暴的研究进展

doi: 10.3760/cma.j.cn501225-20220412-00134
基金项目: 

国家自然科学基金地区科学基金项目 81460293

详细信息
    通讯作者:

    毛远桂,Email:yuanguimao64@163.com

Research advances on severe burn infection and cytokine storm

Funds: 

Regional Science Fund Project of National Natural Science Foundation of China 81460293

More Information
  • 摘要: 严重烧伤的致死率一直处于较高水平。大量研究表明,严重烧伤患者快速出现感染症状、病情进展迅速与细胞因子风暴的发生密切相关,然而临床实践中对细胞因子风暴的监测预警及对症治疗尚处于探索阶段。该文就细胞因子风暴及关联的细胞因子、烧伤感染诱发细胞因子风暴的机制、预警及治疗进行综述,旨在为减轻严重烧伤患者感染程度、降低病死概率提供临床参考建议。

     

  • 参考文献(38)

    [1] TianH,WangLX,XieWG, et al. Epidemiologic and clinical characteristics of severe burn patients: results of a retrospective multicenter study in China, 2011-2015 [J/OL]. Burns Trauma, 2018,6:14[2022-04-12]. https://pubmed.ncbi.nlm.nih.gov/29850643/.DOI: 10.1186/s41038-018-0118-z.
    [2] YoonJ,KymD,HurJ,et al.Comparative usefulness of sepsis-3, burn sepsis, and conventional sepsis criteria in patients with major burns[J].Crit Care Med,2018,46(7):e656-e662.DOI: 10.1097/CCM.0000000000003144.
    [3] 吴田田,童亚林,姚咏明.烧伤创面脓毒症的防治对策[J].创伤外科杂志,2017,19(5):396-400.DOI: 10.3969/j.issn.1009-4237.2017.05.020.
    [4] SapanHB,PaturusiI,JusufI,et al.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma[J].Int J Burns Trauma,2016,6(2):37-43.
    [5] FerraraJL.Cytokine dysregulation as a mechanism of graft versus host disease[J].Curr Opin Immunol,1993,5(5):794-799.DOI: 10.1016/0952-7915(93)90139-j.
    [6] 姚咏明,张卉,李春盛.脓毒症治疗新策略:免疫调理研究新认识[J].医学与哲学,2017,38(2B):28-31,42.DOI: 10.12014/j.issn.1002-0772.2017.02b.04.
    [7] 中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等.中国脓毒症早期预防与阻断急诊专家共识[J].中国急救医学,2020,40(7):577-588.DOI: 10.3969/j.issn.1002-1949.2020.07.001.
    [8] 王玉亮,王峰,耿洁.细胞因子与细胞因子风暴[J].天津医药,2020,48(6):494-499.DOI: 10.11958/20200323.
    [9] TisoncikJR,KorthMJ,SimmonsCP,et al.Into the eye of the cytokine storm[J].Microbiol Mol Biol Rev,2012,76(1):16-32.DOI: 10.1128/MMBR.05015-11.
    [10] ZhouHT,LuXY,HuangJ,et al.Induction of trained immunity protects neonatal mice against microbial sepsis by boosting both the inflammatory response and antimicrobial activity[J].J Inflamm Res,2022,15:3829-3845.DOI: 10.2147/JIR.S363995.
    [11] MulderPPG,VligM,BoekemaBKHL,et al.Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles[J].Front Immunol,2021,11:621222.DOI: 10.3389/fimmu.2020.621222.
    [12] 唐远洋,罗高兴,贺伟峰.严重烧伤感染后细胞因子风暴发生发展机制浅析[J].四川大学学报(医学版),2021,52(1):16-21.DOI: 10.12182/20210160206.
    [13] PandolfiF,AltamuraS,FrosaliS,et al.Key role of DAMP in inflammation, cancer, and tissue repair[J].Clin Ther,2016,38(5):1017-1028.DOI: 10.1016/j.clinthera.2016.02.028.
    [14] TeacheyDT,LaceySF,ShawPA,et al.Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia[J].Cancer Discov,2016,6(6):664-679.DOI: 10.1158/2159-8290.CD-16-0040.
    [15] DucharmeJ,SelfWH,OsbornTM,et al.A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis: proceedings from a clinical advisory panel[J].J Pers Med,2020,10(4):266.DOI: 10.3390/jpm10040266.
    [16] AhmedAI,SolimanRA,SamirS.Cell free DNA and procalcitonin as early markers of complications in ICU patients with multiple trauma and major surgery[J].Clin Lab,2016,62(12):2395-2404.DOI: 10.7754/Clin.Lab.2016.160615.
    [17] JonssonN,NilsenT,Gille-JohnsonP,et al.Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment[J].Crit Care Resusc,2017,19(3):205-213.
    [18] 胡时强,毛远桂,刘德伍,等.严重烧伤脓毒症诊治的研究进展[J].江西医药,2019,54(3):286-288,291.DOI: 10.3969/j.issn.1006-2238.2019.3.034.
    [19] LeeDW,GardnerR,PorterDL,et al.Current concepts in the diagnosis and management of cytokine release syndrome[J].Blood,2014,124(2):188-195.DOI: 10.1182/blood-2014-05-552729.
    [20] BaranP,HansenS,WaetzigGH,et al.The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling[J].J Biol Chem,2018,293(18):6762-6775.DOI: 10.1074/jbc.RA117.001163.
    [21] DholariaBR,BachmeierCA,LockeF.Mechanisms and management of chimeric antigen receptor T-cell therapy-related toxicities[J].BioDrugs,2019,33(1):45-60.DOI: 10.1007/s40259-018-0324-z.
    [22] ShankBR,DoB,SevinA,et al.Chimeric antigen receptor T cells in hematologic malignancies[J].Pharmacotherapy,2017,37(3):334-345.DOI: 10.1002/phar.1900.
    [23] TanakaY,Martin MolaE.IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab[J].Ann Rheum Dis,2014,73(9):1595-1597.DOI: 10.1136/annrheumdis-2013-205002.
    [24] ShakooryB,CarcilloJA,ChathamWW,et al.Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase Ⅲ trial[J].Crit Care Med,2016,44(2):275-281.DOI: 10.1097/CCM.0000000000001402.
    [25] LeventogiannisK,KyriazopoulouE,AntonakosN,et al.Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial[J].Cell Rep Med,2022,3(11):100817.DOI: 10.1016/j.xcrm.2022.100817.
    [26] ChuWM.Tumor necrosis factor[J].Cancer Lett,2013,328(2):222-225.DOI: 10.1016/j.canlet.2012.10.014.
    [27] Cabrera-RiveraGL,Madera-SandovalRL,León-PedrozaJI,et al.Increased TNF-α production in response to IL-6 in patients with systemic inflammation without infection[J].Clin Exp Immunol,2022,209(2):225-235.DOI: 10.1093/cei/uxac055.
    [28] MakosA,KuiperJH,KehoeO,et al.Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors[J].Inflammopharmacology,2023,31(1):77-87.DOI: 10.1007/s10787-022-01092-x.
    [29] ConfalonieriM,SaltonF,FabianoF.Acute respiratory distress syndrome[J].Eur Respir Rev,2017,26(144):160116.DOI: 10.1183/16000617.0116-2016.
    [30] BatzofinBM,SprungCL,WeissYG.The use of steroids in the treatment of severe sepsis and septic shock[J].Best Pract Res Clin Endocrinol Metab,2011,25(5):735-743.DOI: 10.1016/j.beem.2011.05.006.
    [31] HemingN,SivanandamoorthyS,MengP,et al.Immune effects of corticosteroids in sepsis[J].Front Immunol,2018,9:1736.DOI: 10.3389/fimmu.2018.01736.
    [32] HeF,SongY,YingWJ,et al.Effects of Ulinastatin on myocardial oxidative stress and inflammation in severely burned rats[J].Eur Rev Med Pharmacol Sci,2018,22(17):5719-5728.DOI: 10.26355/eurrev_201809_15840.
    [33] ChiYF,LiuXY,ChaiJK.A narrative review of changes in microvascular permeability after burn[J].Ann Transl Med,2021,9(8):719.DOI: 10.21037/atm-21-1267.
    [34] LongbrakeEE,HaflerDA.Siponimod chips away at progressive MS[J].Cell,2019,179(7):1440.DOI: 10.1016/j.cell.2019.11.034.
    [35] GauthierJ,HirayamaAV,PurusheJ,et al.Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure[J].Blood,2020,135(19):1650-1660.DOI: 10.1182/blood.2019002936.
    [36] StaedtkeV,BaiRY,KimK,et al.Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome[J].Nature,2018,564(7735):273-277.DOI: 10.1038/s41586-018-0774-y.
    [37] GrazioliA,AthaleJ,TanakaK,et al.Perioperative applications of therapeutic plasma exchange in cardiac surgery: a narrative review[J].J Cardiothorac Vasc Anesth,2020,34(12):3429-3443.DOI: 10.1053/j.jvca.2020.01.054.
    [38] 肖刘牛,钟燕霞,李树生.体外血液净化技术对脓毒症临床预后及细胞因子影响的Meta分析[J].临床荟萃,2022,37(1):5-13.DOI: 10.3969/j.issn.1004-583X.2022.01.001.
  • 表1  与细胞因子风暴相关联的6类细胞因子及其功能

    类型 主要细胞因子 功能
    CSF G-CSF、M-CSF、GM-CSF 刺激炎症细胞增殖和分化
    IL IL-1~40 活化或诱导免疫细胞增殖和分化
    趋化因子 CCL1~19、CXCL10/IP-10、CXCL12、CX3CL1 控制所有免疫细胞的迁移和归巢,参与炎症反应
    干扰素 α干扰素、β干扰素、γ干扰素 激活巨噬细胞,诱导上皮细胞凋亡
    生长因子 IGF、TGF-β、EGF、PDGF 促进细胞生长、分化和个体发育
    TNF TNF-α、TNF-β 促进炎症反应,激活细胞毒性T淋巴细胞,调控细胞的增殖、存活、分化和凋亡
    注:CSF为集落刺激因子,IL为白细胞介素,TNF为肿瘤坏死因子,G-CSF为粒细胞集落刺激因子,M-CSF为巨噬细胞集落刺激因子,GM-CSF为粒细胞巨噬细胞集落刺激因子,IP-10为γ干扰素诱导蛋白10,IGF为胰岛素样生长因子,TGF-β为转化生长因子β,EGF为表皮生长因子,PDGF为血小板衍生生长因子
    下载: 导出CSV
  • 加载中
表(1)
计量
  • 文章访问数:  279
  • HTML全文浏览量:  86
  • PDF下载量:  42
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-04-12

目录

    /

    返回文章
    返回